UnknownNot Applicable

Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health Disorders

Canada32 participantsStarted 2019-09-24

Plain-language summary

This is a proof-of-concept of a new Virtual Reality (VR) Avatar Intervention for Cannabis Use Disorders (CUD) in patients with psychotic disorders and/or mood disorders. The primary outcomes are reductions in cannabis use, cannabis use disorder severity, and increased quality of life.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Males or females over 18 years of age who meet the DSM-5 criteria for CUD (≥4 criteria) ; * Patients will meet the DSM-5 criteria for schizophrenia, schizoaffective disorder, bipolar disorder and major depression. Diagnoses will be established with the Structured Interview for DSM-5 (SCID-5). Exclusion Criteria: * Ongoing pharmacological or psychological treatment for CUD ; * Ongoing detoxification for cannabis withdrawal ; * Presence of neurological disorders ; * Presence of a severe and unstable physical illness ; * Inability to provide consent.

What they're measuring

Change in cannabis use (Timeline Follow-Back)

Timeframe: Within 1 week before treatment, within 1 week after treatment as well as 3- 6- and 12-months follow-up

Trial details

NCT IDNCT05726617

SponsorCiusss de L'Est de l'Île de Montréal

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-08-11

View on ClinicalTrials.gov More Psychotic Disorders trials